Use of an automated ACTH assay for the diagnosis of pituitary and adrenal-related diseases.
Brossaud J, Bouton M, Gatta B, Tabarin A, Corcuff JB
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effect of assay type on the measurement of ACTH in plasma from healthy individuals, and patients with Cushing's syndrome, adrenal tumors, or adrenal insufficiency. Fresh plasma was analyzed by IRMA, and plasma frozen at -80 degrees C prior to analysis was used for the Liaison assay.
Summary of Findings
There were no clinical discrepancies in ACTH levels between assays, but there was significant analytical bias. Importantly, using the Liaison assay, ACTH levels were below the limit of quantification for 25% of specimens from normal individuals, but all specimens were above the limit of detection of the IRMA. The IRMA was better able to segregate patients with ACTH-independent and ACTH-dependent Cushing's syndrome, while the Liaison assay was adequate for classifying primary versus secondary adrenal insufficiency.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
NeoplasticCarcinomaNeoplasticNeoplasticBenignNormalOther diagnosesPlatforms
PeptideImmunoradiometric assayPeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Adrenal insufficiencyCushing's diseaseClinical chemistry/auto analyzer Specific Technology platform IRMA